32 results
8-K
EX-99.1
LBPH
Longboard Pharmaceuticals, Inc.
1 Aug 24
Longboard Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
4:10pm
that still exists for so many patients. I want to thank the entire DEE community for this important milestone because this was the culmination of years
8-K
EX-99.1
LBPH
Longboard Pharmaceuticals, Inc.
1 Jul 24
Regulation FD Disclosure
9:15am
for the DEE community. Most of those living with DEEs do not have access to novel medications, nor have they had the opportunity to participate in trials … ; the DEE community; Longboard’s ability to develop product candidates and deliver medicines; Longboard’s focus and work; and LP659, including its potential
PRE 14A
nm3emk8b
28 Mar 24
Preliminary proxy
4:36pm
8-K
EX-99.1
ysrsli
12 Mar 24
Longboard Pharmaceuticals Reports Full Year 2023 Financial Results and Provides Corporate Updates
4:10pm
8-K
EX-99.1
826t4jmz ayyn06c
2 Jan 24
Regulation FD Disclosure
9:44am
8-K
gnqwxa743vz9c76 ecd
2 Jan 24
Regulation FD Disclosure
9:44am
8-K
EX-99.1
55es2m4x
2 Nov 23
Longboard Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2023 Financial Results
4:05pm
8-K
EX-99.1
x3vrtpe6fuuahccglh
23 Aug 23
Enrolled 52 participants with Developmental and Epileptic Encephalopathies (DEEs) into the PACIFIC Study
8:46am
8-K
EX-99.1
urm863
9 May 23
Longboard Pharmaceuticals Provides Corporate Update and Reports First Quarter 2023 Financial Results
4:06pm
8-K
EX-99.1
f0eguir7pvpz
4 Aug 22
Longboard Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2022 Financial Results
4:19pm